%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png)
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2024年年度权益分派实施公告 | 2025-05-23 | Chinese | |
| 关于公司股东减持股份实施情况的公告 | 2025-05-21 | Chinese | |
| 关于实施权益分派期间药石转债暂停转股的提示性公告 | 2025-05-19 | Chinese | |
| 关于变更财务负责人的公告 | 2025-05-16 | Chinese | |
| 第四届董事会第七次会议决议公告 | 2025-05-16 | Chinese | |
| 药石科技2024年度股东大会法律意见书 | 2025-05-16 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 40023940 | 2024年年度权益分派实施公告 | 2025-05-23 | Chinese | ||
| 40023930 | 关于公司股东减持股份实施情况的公告 | 2025-05-21 | Chinese | ||
| 40023919 | 关于实施权益分派期间药石转债暂停转股的提示性公告 | 2025-05-19 | Chinese | ||
| 40023915 | 关于变更财务负责人的公告 | 2025-05-16 | Chinese | ||
| 40023904 | 第四届董事会第七次会议决议公告 | 2025-05-16 | Chinese | ||
| 40023897 | 药石科技2024年度股东大会法律意见书 | 2025-05-16 | Chinese | ||
| 40023888 | 2024年度股东大会决议公告 | 2025-05-16 | Chinese | ||
| 40023879 | 第四届董事会第六次会议决议公告 | 2025-05-16 | Chinese | ||
| 40023863 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司2024年度持续督导跟踪报告 | 2025-05-12 | Chinese | ||
| 40023854 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司2024年度现场检查报告 | 2025-05-12 | Chinese | ||
| 40023844 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司2024年度持续督导的培训报告 | 2025-05-12 | Chinese | ||
| 40023834 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司向不特定对象发行可转换公司债券并在创业板上市之保荐总结报告书 | 2025-05-12 | Chinese | ||
| 40023830 | 关于公司股东减持股份的预披露公告 | 2025-05-05 | Chinese | ||
| 40023818 | 2024年环境、社会及公司治理(ESG)报告 | 2025-04-30 | Chinese | ||
| 40023795 | 关于控股股东、实际控制人部分股份解除质押的公告 | 2025-04-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.